Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Inogen, Inc. (INGN)

NMS · Medical Devices

$6.42+0.11 (+1.74%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$173.8M
P/E (TTM)
EPS
$-0.91
Div Yield
52W Range
$5.34–$9.13
Beta
1.59

Company overview

Next earnings: 2026-08-06(9d)

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Peers in Medical Devices

All in industry →

Recent press releases

April 2026

3 months ago8-KHealthcare

Inogen Inc — 8-K Filing

INGNInogen Inc

# 🧾 What This Document Is This is an 8-K filing, which companies use to announce major events to investors. It contains two main exhibits: a **Cooperation Agreement** with an activist investor (Kent Lake) and a **press release** announcing a new board member. In short, it's a peace treaty and a bo

Read summaryView on SEC EDGAR

March 2026

4 months ago8-KHealthcare

Inogen Inc — 8-K Filing

INGNInogen Inc

# 📄 What This Document Is This is an **8-K filing**, which is a report companies must file with the SEC to announce major events that shareholders should know about. This specific filing has two big announcements: the detailed **employment contract for a new Chief Financial Officer (CFO)** and a **

Read summaryView on SEC EDGAR

SEC filings

All filings →
2 recent filings shown in the timeline above. View all SEC filings →

Inogen, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
1,716,838 sh+1.6%
1,421,636 sh-0.6%
711,380 sh-14.6%
458,100 sh-17.3%
1,264,000 sh+46.3%
201,949 sh● NEW
549,470 sh-8.6%
558,368 sh-7.8%

People at Inogen, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$32.0M
NI -$6.2M
06/25
$92.3M
NI -$4.2M
09/25
$92.4M
NI -$5.3M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.20
Prior: $-0.15
Revenue sparkline